Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synergistic Interactions of Cannabidiol with Chemotherapeutic Drugs in MCF7 Cells: Mode of Interaction and Proteomics Analysis of Mechanisms
Muhammad A. Alsherbiny, Deep Jyoti Bhuyan, Mitchell Low, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 10103-10103
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

A Comprehensive Review on the Techniques for Extraction of Bioactive Compounds from Medicinal Cannabis
H.M.S. Al Ubeed, Deep Jyoti Bhuyan, Muhammad A. Alsherbiny, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 604-604
Open Access | Times Cited: 86
Mechanisms of Cannabidiol (CBD) in Cancer Treatment: A Review
Camren G. Heider, Sasha A. Itenberg, Jiajia Rao, et al.
Biology (2022) Vol. 11, Iss. 6, pp. 817-817
Open Access | Times Cited: 62
The molecular activity of cannabidiol in the regulation of Nrf2 system interacting with NF-κB pathway under oxidative stress
Sinemyiz Atalay, Agnieszka Gęgotek, Elżbieta Skrzydlewska
Redox Biology (2022) Vol. 57, pp. 102489-102489
Open Access | Times Cited: 54
Drug–Drug Interactions of Cannabidiol with Standard-of-Care Chemotherapeutics
Tereza Buchtová, David Lukac, Zdeněk Škrott, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2885-2885
Open Access | Times Cited: 23
Potential, Limitations and Risks of Cannabis-Derived Products in Cancer Treatment
Herman J. Woerdenbag, Peter Olinga, Ellen A. Kok, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2119-2119
Open Access | Times Cited: 17
Buds and Bugs: A Fascinating Tale of Gut Microbiota and Cannabis in the Fight against Cancer
Ahmad K. Al-Khazaleh, Kayla Jaye, Dennis Chang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 872-872
Open Access | Times Cited: 5
Exploring the therapeutic potential of cannabinoids in cancer by modulating signaling pathways and addressing clinical challenges
Manal Bint Faiz, Faiza Naeem, Muhammad Irfan, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Investigating the Multi-Mechanistic Anticancer Effects of 4-Bisarylurea Thiouracil Derivatives in Breast Cancer Cells
Mohamed Fares, Muhammad A. Alsherbiny, Islam A. Elkelesh, et al.
(2025)
Closed Access
Mechanisms of Cell Death Induced by Cannabidiol Against Tumor Cells: A Review of Preclinical Studies
Eduarda B. S. de Melo, Estéfani Alves Asevedo, Joaquim Maurício Duarte‐Almeida, et al.
Plants (2025) Vol. 14, Iss. 4, pp. 585-585
Open Access
Combination of Cannabidiol with Cisplatin or Paclitaxel Analysis Using the Chou–Talalay Method and Chemo-Sensitization Evaluation in Platinum-Resistant Ovarian Cancer Cells
Jana Ismail, Wassim N. Shebaby, Shirine Azar-Atallah, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 520-520
Open Access
Effect of cannabinoids on the efficacy and side effects of anticancer therapeutic strategies – Current status of preclinical and clinical research
Robert Ramer, Burkhard Hinz
Pharmacology & Therapeutics (2025), pp. 108851-108851
Closed Access
Potential applications of hemp (Cannabis sativa L.) extracts and their phytochemicals as functional ingredients in food and medicinal supplements: a narrative review
H.M.S. Al Ubeed, Charles S. Brennan, Ellen Schanknecht, et al.
International Journal of Food Science & Technology (2022) Vol. 57, Iss. 12, pp. 7542-7555
Open Access | Times Cited: 17
Drug–Cannabinoid Interactions in Selected Therapeutics for Symptoms Associated with Epilepsy, Autism Spectrum Disorder, Cancer, Multiple Sclerosis, and Pain
María G. Campos, Maria La China, Mariana Cláudio, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 613-613
Open Access | Times Cited: 3
Improved Therapeutic Efficacy of Doxorubicin Chemotherapy With Cannabidiol in 4T1 Mice Breast Cancer Model
Koorosh Tabatabaei, Sara Moazzezi, Mohammadreza Emamgholizadeh, et al.
Cancer Medicine (2024) Vol. 13, Iss. 21
Open Access | Times Cited: 2
A multi-scale feature fusion model based on biological knowledge graph and transformer-encoder for drug-drug interaction prediction
Tao Wang, Qiang Deng, Jialu Hu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
The postbiotic sodium butyrate synergizes the antiproliferative effects of dexamethasone against the AGS gastric adenocarcinoma cells
Radwa A. Eladwy, Muhammad A. Alsherbiny, Dennis Chang, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 2
Molecular Targets of Minor Cannabinoids in Breast Cancer: In Silico and In Vitro Studies
Cristina Ferreira Almeida, Andreia Palmeira, Maria João Valente, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 9, pp. 1245-1245
Open Access | Times Cited: 2
Mechanistic Insights into the Anti-Proliferative Action of Gut Microbial Metabolites against Breast Adenocarcinoma Cells
Kayla Jaye, Muhammad A. Alsherbiny, Dennis Chang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15053-15053
Open Access | Times Cited: 6
Cannabidiol's impact on drug-metabolization
Claudia Stöllberger, Josef Finsterer
European Journal of Internal Medicine (2023) Vol. 118, pp. 6-13
Closed Access | Times Cited: 5
Potential Drug Interactions with Cannabinoids in Selected Chronic Diseases: Epilepsy, Autism Spectrum Disorders, Oncology, Multiple Sclerosis and Pain
María G. Campos, Maria La China, Mariana Cláudio, et al.
(2024)
Open Access | Times Cited: 1
From Sea to Science: Coral Aquaculture for Sustainable Anticancer Drug Development
Hung‐Yu Lin, Tsen‐Ni Tsai, Kai‐Cheng Hsu, et al.
Marine Drugs (2024) Vol. 22, Iss. 7, pp. 323-323
Open Access | Times Cited: 1
Trustworthy Deep Neural Network for Inferring Anticancer Synergistic Combinations
Muhammad A. Alsherbiny, Ibrahim Radwan, Nour Moustafa, et al.
IEEE Journal of Biomedical and Health Informatics (2021) Vol. 27, Iss. 4, pp. 1691-1700
Closed Access | Times Cited: 9
Cannabis with breast cancer treatment: propitious or pernicious?
Recardia Schoeman, Amy de la Harpe, Natasha Beukes, et al.
3 Biotech (2022) Vol. 12, Iss. 2
Open Access | Times Cited: 6
PCF11, a Novel CD44-Downstream Transcriptional Target, Linking Its 3’-End Polyadenylation Function to Tumor Cell Metastasis
Maryam Al‐Mansoob, Salma M. S. Ahmad, Allal Ouhtit
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 4
Selected phytocannabinoids inhibit SN-38- and cytokine-evoked increases in epithelial permeability and improve intestinal barrier function in vitro
Dylan T. Marsh, Scott D. Smid
Toxicology in Vitro (2024) Vol. 99, pp. 105888-105888
Open Access
Page 1 - Next Page

Scroll to top